Isobutyryl-carfentanyl has strong acute toxicity and analgesic effects with high addiction potential
- PMID: 39110217
- DOI: 10.1007/s00213-024-06664-z
Isobutyryl-carfentanyl has strong acute toxicity and analgesic effects with high addiction potential
Abstract
Rationale: Isobutyryl-carfentanyl is the most recently discovered fentanyl analogue with a chemical structure that is similar to that of carfentanyl. Its analogue, carfentanyl, is regarded as one of the most lethal drugs in the world, with a potency of 10,000 times that of morphine. Therefore, isobutyryl-carfentanyl may possess a comparably high potency and its harmful effects cannot be ignored.
Objectives: This study was designed to assess the analgesic effect of isobutyryl-carfentanyl and the potential risks associated with its misuse.
Methods: In this study, we assessed the acute toxicity of isobutyryl-carfentanyl by up-and-down-procedure, the analgesic efficacy by hot-plate test, the abuse potential by conditioned place preference (CPP), drug self-administration, and drug discrimination tests, and compared it with fentanyl and carfentanyl.
Results: The estimated median lethal dose (LD50) of isobutyryl-carfentanyl administered were 175 mg/kg (intragastric administration, IG), 15.84 mg/kg (intraperitoneal injection, IP), 15.84 mg/kg (subcutaneous injection, SC), and 1.6 mg/kg (intravenous injection, IV), respectively. The 50% maximal analgesic effect (ED50) of isobutyryl-carfentanyl was determined to be 0.00319 mg/kg, with an analgesic potency 14 times that of fentanyl and 0.82 times that of carfentanyl. Isobutyryl-carfentanyl exhibited a significant positional preference at a minimum dose of 0.1 mg/kg, while fentanyl exhibited a significant positional preference at a minimum dose of 0.3 mg/kg. In the heroin (0.05 mg/kg/infusion) self-administration substitution experiment, isobutyryl-carfentanyl showed significant self-administration behaviour at doses of 0.0005-0.001 mg/kg/infusion, with the maximum number of infusions observed at a dose of 0.001 mg/kg. In the heroin (1 mg/kg) drug discrimination experiment, fentanyl (0.005-0.02 mg/kg), carfentanyl (0.0005-0.002 mg/kg), and isobutyryl-carfentanyl (0.001-0.005 mg/kg) were tested in the dose-effect curves. The results showed that all three drugs exhibit dose-dependent increase in the number of drug-associated nose pokes responses and reduction in the rate of nose pokes. The subjective effect potency of isobutyryl-carfentanyl was found to be 4.4 times that of fentanyl and 0.5 times that of carfentanyl.
Conclusions: In summary, isobutyryl-carfentanyl has high acute toxicity and analgesic effect, with strong psychological dependence approximately 5 times that of fentanyl and 0.5 times that of carfentanyl, and has extremely high abuse potency.
Keywords: Analgesia; Carfentanyl; Conditioned place preference; Drug discrimination; Fentanyl; Isobutyryl-carfentanyl; Self-administration.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: All procedures followed the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Conflict of interest: The authors declare no conflict of interest related to this work.
References
-
- Araldi D, Ferrari LF, Levine JD (2018) Mu-opioid receptor (MOR) biased agonists induce biphasic dose-dependent hyperalgesia and analgesia, and hyperalgesic priming in the rat. Neuroscience 394:60–71. https://doi.org/10.1016/j.neuroscience.2018.10.015 - DOI - PubMed
-
- Armenian P, Vo KT, Barr-Walker J, Lynch KL (2018) Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review. Neuropharmacology 134:121–132. https://doi.org/10.1016/j.neuropharm.2017.10.016 - DOI - PubMed
-
- Assar N, Mahmoudi D, Farhoudian A et al (2016) D1- and D2-like dopamine receptors in the CA1 region of the hippocampus are involved in the acquisition and reinstatement of morphine-induced conditioned place preference. Behav Brain Res 312:394–404. https://doi.org/10.1016/j.bbr.2016.06.061 - DOI - PubMed
-
- Belin-Rauscent A, Fouyssac M, Bonci A, Belin D (2016) How preclinical models evolved to resemble the diagnostic criteria of drug addiction. Biol Psychiatry 79:39–46. https://doi.org/10.1016/j.biopsych.2015.01.004 - DOI - PubMed
-
- Bozarth MA (1994) Opiate reinforcement processes: re-assembling multiple mechanisms. Addiction 89:1425–1434. https://doi.org/10.1111/j.1360-0443.1994.tb03739.x - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
